Neuland Laboratories Ltd. Financials: Quarterly Results
Revenue
788.71
Cr.
PAT
212.67
Cr.
EBITDA
294.70
Cr.
Neuland Laboratories Ltd. Q4FY26 Financial Metrics
| Indicator | Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 776.25 | 439.71 | 514.27 | 292.75 | 328.36 |
| Total Income From Operations (Cr.) | 776.25 | 439.71 | 514.27 | 292.75 | 328.36 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 294.70 | 61.27 | 134.80 | 22.16 | 41.65 |
| P/L Before Exceptional Items & Tax (Cr.) | 287.49 | 54.48 | 129.44 | 17.57 | 39.30 |
| P/L After Tax from Ordinary Activities (Cr.) | 212.67 | 40.57 | 96.85 | 13.90 | 27.81 |
| Net Profit/Loss For the Period (Cr.) | 212.67 | 40.57 | 96.85 | 13.90 | 27.81 |
| Basic EPS | 165.76 | 31.62 | 75.49 | 10.83 | 21.67 |
FAQs
Neuland Laboratories Ltd. announced its quarterly results for Q4 FY2026 on May 12, 2026.
In Q4 FY2026, Neuland Laboratories Ltd. are as follows:
Revenue: ₹788.71 crore
Net Profit: ₹212.67 crore.
For Q4 FY2026, Neuland Laboratories Ltd. posted ₹788.71 crore in revenue and ₹212.67 crore in net profit.
Past quarterly results for Neuland Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.